References
- Silverberg MS, Satsangi J, Ahmad T, et al. Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a working party of the 2005 Montreal World Congress of Gastroenterology. Can J Gastroenterol. 2005;19:5A–36A.
- Calafat M, Lobatón T, Mañosa M, et al. Requerimientos terapéuticos en el tratamiento de los brotes de la proctitis ulcerosa. Estudio unicéntrico. Gastroenterol Hepatol. 2017;40:663–668.
- Gecse KB, Lakatos PL. Ulcerative proctitis: an update on the pharmacotherapy and management. Expert Opin Pharmacother. 2014;15:1565–1573.
- Torres J, Billioud V, Sachar DB, et al. Ulcerative colitis as a progressive disease: the forgotten evidence. Inflamm Bowel Dis. 2012;18:1356–1363.
- Katz J. The course of inflammatory bowel disease. Med Clin North Am. 1994;78:1275–1280.
- Huguet JM, Suárez P, Ferrer-Barceló L, et al. Endoscopic recommendations for colorectal cancer screening and surveillance in patients with inflammatory bowel disease: review of general recommendations. World J Gastrointest Endosc. 2017;9:255–262.
- Roda G, Narula N, Pinotti R, et al. Systematic review with meta-analysis: proximal disease extension in limited ulcerative colitis. Aliment Pharmacol Ther. 2017;45:1481–1492.
- Huguet JM, Ferrer-Barceló L, Suárez P, et al. Progresión endoscópica de la proctitis ulcerosa a formas más extensas de la enfermedad. Gastroenterol Hepatol. 2018;41:191.
- Schroeder KW, Tremaine WJ, Ilstrup DM. Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis. N Engl J Med. 1987;317:1625–1629.
- Barreiro-De Acosta M, Magro F, Carpio D, et al. Ulcerative colitis in northern Portugal and Galicia in Spain. Inflamm Bowel Dis. 2010;16:1227–1238.
- Naves JE, Lorenzo-Zúñiga V, Marín L, et al. Long-term outcome of patients with distal ulcerative colitis and inflammation of the appendiceal orifice. J Gastrointest Liver Dis. 2011;20:355–358.
- Belkin E, Cherng N, Pellish RP. 054 Progression of ulcerative proctitis to proximal disease. Inflamm Bowel Dis. 2013;19:S48–S49.
- Walsh E, Chah YW, Chin SM, et al. Clinical predictors and natural history of disease extension in patients with ulcerative proctitis. Inflamm Bowell Dis. 2017;23:2035–2041.
- Kim B, Park SJ, Hong SP, et al. Proximal disease extension and related predicting factors in ulcerative proctitis. Scand J Gastroenterol. 2014;49:177–183.
- Anzai H, Hata K, Kishikawa J, et al. Clinical pattern and progression of ulcerative proctitis in the Japanese population: a retrospective study of incidence and risk factors influencing progression. Colorectal Dis. 2016;18:O97–O102.
- Anzai H, Hata K, Kishikawa J, et al. Appendiceal orifice inflammation is associated with proximal extension of disease in patients with ulcerative colitis. Colorectal Dis. 2016;18:O278–O282.
- Langholz E, Munkholm P, Davidsen M, et al. Changes in extent of ulcerative colitis: a study on the course and prognostic factors. Scand J Gastroenterol. 1996;31:260–266.
- Meucci G, Vecchi M, Astegiano M, et al. The natural history of ulcerative proctitis: a multicenter, retrospective study. Am J Gastroenterol. 2000;95:469–473.
- Alkim C, Alkim H, Dağli U, et al. Extension of ulcerative colitis. Turk J Gastroenterol. 2011;22:382–387.
- Solberg IC, Lygren I, Jahnsen J, et al. IBSEN Study Group. Clinical course during the first 10 years of ulcerative colitis results from a population based inception cohort IBSEN Study. Scand J Gastroenterol. 2009;44:431–440.
- Sahami S, Konté K, Buskens CJ, et al. Risk factors for proximal disease extension and colectomy in left-sided ulcerative colitis. United Eur Gastroenterol J. 2017;5:554–562.
- Burisch J, Ungaro R, Vind I, et al. Proximal disease extension in patients with limited ulcerative colitis: a Danish population based inception cohort. J Crohn’s Colitis. 2017;11:1200–1204.